- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06642311
Bladder Distension for Pain Relief in Patients With Excessive Anteflexion of Uterus Undergoing Office Hysteroscopy
Bladder Distension for Pain Relief in Patients With Excessive Anteflexion of Uterus Undergoing Office Hysteroscopy: a Randomized Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Usama M Fouda, Prof.
- Phone Number: +2 01095401375
- Email: umfrfouda@kasralainy.edu.eg
Study Locations
-
-
-
Cairo, Egypt
- Recruiting
- Obstetrics &Gynecology Department , Faculty of medicine ,Cairo university
-
Principal Investigator:
- Usama M Fouda, Prof
-
Contact:
- Usama M Fouda, Prof
- Phone Number: 01095401375
- Email: umfrfouda@kasralainy.edu.eg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients with excessive anteflexion of the uterus
Exclusion Criteria:
- Cervical pathology
- Previous cervical surgery
- Severe vaginal bleeding
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Bladder distension group
Patients in the bladder distension group will be instructed to drink one liter of water and to avoid urination during a period of 2 h before the scheduled procedure. A colleague will perform transabdominal ultrasound to confirm that the bladder is distended . All the procedures will be performed using the vaginoscopic technique. A rigid 2.9-mm hysteroscope with a 30° lens and a 5-mm outer sheath (Karl Storz GmbH, Tuttlingen, Germany) will be used in all procedures. |
Patients in the bladder distension group will be instructed to drink one liter of water and to avoid urination during a period of 2 h before the scheduled procedure.
A colleague will perform transabdominal ultrasound to confirm that the bladder is distended .
All the procedures will be performed using the vaginoscopic technique.
A rigid 2.9-mm hysteroscope with a 30° lens and a 5-mm outer sheath (Karl Storz GmbH, Tuttlingen, Germany) will be used in all procedures.
|
|
Active Comparator: Empty bladder group
Patients in the empty bladder group will be instructed to empty the bladder immediately before the procedure. A colleague will perform transabdominal ultrasound to confirm that the bladder is empty. All the procedures will be performed using the vaginoscopic technique. A rigid 2.9-mm hysteroscope with a 30° lens and a 5-mm outer sheath (Karl Storz GmbH, Tuttlingen, Germany) will be used in all procedures |
Patients in the empty bladder group will be instructed to empty the bladder immediately before the procedure.
A colleague will perform transabdominal ultrasound to confirm that the bladder is empty.
All the procedures will be performed using the vaginoscopic technique.
A rigid 2.9-mm hysteroscope with a 30° lens and a 5-mm outer sheath (Karl Storz GmbH, Tuttlingen, Germany) will be used in all procedures.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intensity of pain
Time Frame: : Immediately after the procedure
|
Measured using 100 mm visual analogue scale ( 0 = no pain and 100 = worst possible pain)
|
: Immediately after the procedure
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Usama M Fouda, Prof,, Cairo University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Anteflexion /hysteroscoy
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hysteroscopy
-
Wenzhou Medical UniversityCompleted
-
Cairo UniversityAljazeera HospitalRecruiting
-
Cairo UniversityCompleted
-
Indonesia UniversityCompletedOffice HysteroscopyIndonesia
-
Cairo UniversityCompleted
-
Baoding First Central HospitalNot yet recruitingPainless Hysteroscopy
-
EgymedicalpediaCompleted
-
University of Campinas, BrazilUnknownHysteroscopy | Postmenopausal WomenBrazil
-
Ospedale degli Infermi di BiellaRecruitingPain During Outpatient HysteroscopyItaly
Clinical Trials on Empty bladder group
-
Cairo UniversityBedaya HospitalNot yet recruiting
-
Lancashire Teaching Hospitals NHS Foundation TrustCompletedProstate Cancer | Radiotherapy Side EffectUnited Kingdom
-
Institut Cancerologie de l'OuestCompleted
-
Guohua ZengUnknown
-
Cairo UniversityCompletedBladder Injury | Accreta, PlacentaEgypt
-
Orion Corporation, Orion PharmaCompletedPulmonary Disease, Chronic Obstructive | AsthmaUnited Kingdom, Finland
-
Yanyan GongXiangya Hospital of Central South University; Renmin Hospital of Wuhan University and other collaboratorsNot yet recruitingIntracerebral Hemorrhage | Targeted Temperature Management
-
University of California, Los AngelesTobacco Related Disease Research ProgramCompleted
-
Samuel Lunenfeld Research Institute, Mount Sinai...Completed